青少年抑郁症的光疗法:一个大范围的审查
Rachel Ballard1, John Parkhurst1, Kelsey Julian1
1Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Ave, Box 10, 60611, Chicago, IL, USA.
Current psychiatry reports
|July 25, 2023
概括
明亮光疗法 (BLT) 在青少年抑郁症方面表现有前途. 需要更多的研究来证实它对年轻人的有效性和适用性,并建立在成人研究的基础上.
科学领域:
- 精神病学是一个精神病学.
- 青少年医学 青少年医学
- 心理健康治疗 心理健康治疗
背景情况:
- 青少年抑郁症对发展,社会融合和教育构成重大风险.
- 明亮光疗法 (BLT) 是一种成熟的成人抑郁症治疗方法,但其在青少年中的应用尚未得到充分研究.
- 现有研究强调了对儿科患者群体进行更多受控试验的必要性.
研究的目的:
- 对当前关于治疗青少年抑郁症的明亮光疗法 (BLT) 的知识进行范围审查.
- 为儿科和年轻成年人群确定BLT研究中的新数据和方法方法.
- 评估BLT在青少年抑郁症中的可行性和有效性.
主要方法:
- 在文献中搜索有关青少年抑郁症明亮光疗法 (BLT) 的研究.
- 对儿科BLT研究中的新数据和方法进步的审查.
- 对BLT耐受性和副作用概况的现有证据的分析.
主要成果:
- 亮光疗法 (BLT) 在青少年群体中通常耐受良好,副作用最小.
- 显著缺乏评估BLT治疗青少年抑郁症疗效的有力的研究.
- 成人研究的证据表明潜在的益处,需要在青少年身上进行进一步的研究.
结论:
- 明亮光疗法 (BLT) 是青少年抑郁症的潜在可行的治疗选择.
- 进一步的研究对于确定BLT在青少年中的有效性,可行性和可接受性至关重要.
- 需要精心设计的受控试验来支持使用BLT治疗青少年抑郁症.
相关概念视频
Depression: Overview
280
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
280
Antidepressant Drugs: MAOIs and Other Agents
275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275
Long-term Depression
31.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.0K
Depressive Disorders: MDD and Dysthymia
176
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
176
Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Depressive Disorders: Etiology
140
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
140


